These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 7613473)

  • 21. The immunological functions of saposins.
    Darmoise A; Maschmeyer P; Winau F
    Adv Immunol; 2010; 105():25-62. PubMed ID: 20510729
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural study of the oligosaccharide moieties of sphingolipid activator proteins, saposins A, C and D obtained from the spleen of a Gaucher patient.
    Ito K; Takahashi N; Takahashi A; Shimada I; Arata Y; O'Brien JS; Kishimoto Y
    Eur J Biochem; 1993 Jul; 215(1):171-9. PubMed ID: 8344278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural and membrane-binding properties of saposin D.
    Tatti M; Salvioli R; Ciaffoni F; Pucci P; Andolfo A; Amoresano A; Vaccaro AM
    Eur J Biochem; 1999 Jul; 263(2):486-94. PubMed ID: 10406958
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Crystal structure of saposin B reveals a dimeric shell for lipid binding.
    Ahn VE; Faull KF; Whitelegge JP; Fluharty AL; Privé GG
    Proc Natl Acad Sci U S A; 2003 Jan; 100(1):38-43. PubMed ID: 12518053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Solution structure of human saposin C: pH-dependent interaction with phospholipid vesicles.
    de Alba E; Weiler S; Tjandra N
    Biochemistry; 2003 Dec; 42(50):14729-40. PubMed ID: 14674747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of calcium on phosphatidylserine- and saposin C-stimulated glucosylceramide beta-glucosidase activity.
    Prence EM
    Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):571-5. PubMed ID: 7654196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mutations causing Gaucher disease.
    Horowitz M; Zimran A
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The primary structure of mouse saposin.
    Tsuda M; Sakiyama T; Endo H; Kitagawa T
    Biochem Biophys Res Commun; 1992 May; 184(3):1266-72. PubMed ID: 1590788
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential membrane interactions of saposins A and C: implications for the functional specificity.
    Qi X; Grabowski GA
    J Biol Chem; 2001 Jul; 276(29):27010-7. PubMed ID: 11356836
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Saposin C is required for normal resistance of acid beta-glucosidase to proteolytic degradation.
    Sun Y; Qi X; Grabowski GA
    J Biol Chem; 2003 Aug; 278(34):31918-23. PubMed ID: 12813057
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mouse testicular sulfated glycoprotein-1: sequence analysis of the common backbone structure of prosaposins.
    Zhao Q; Bell AW; El-Alfy M; Morales CR
    J Androl; 1998; 19(2):165-74. PubMed ID: 9570739
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Function of saposin C in the reconstitution of glucosylceramidase by phosphatidylserine liposomes.
    Vaccaro AM; Tatti M; Ciaffoni F; Salvioli R; Maras B; Barca A
    FEBS Lett; 1993 Dec; 336(1):159-62. PubMed ID: 8262201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sphingolipid hydrolase activator proteins and their precursors.
    Sano A; Hineno T; Mizuno T; Kondoh K; Ueno S; Kakimoto Y; Inui K
    Biochem Biophys Res Commun; 1989 Dec; 165(3):1191-7. PubMed ID: 2610686
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stimulation of acid ceramidase activity by saposin D.
    Azuma N; O'Brien JS; Moser HW; Kishimoto Y
    Arch Biochem Biophys; 1994 Jun; 311(2):354-7. PubMed ID: 8203897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acid sphingomyelinase possesses a domain homologous to its activator proteins: saposins B and D.
    Ponting CP
    Protein Sci; 1994 Feb; 3(2):359-61. PubMed ID: 8003971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of carbohydrate removal on stability and activity of saposin B.
    Hiraiwa M; Soeda S; Martin BM; Fluharty AL; Hirabayashi Y; O'Brien JS; Kishimoto Y
    Arch Biochem Biophys; 1993 Jun; 303(2):326-31. PubMed ID: 8099782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intracellular degradation of fluorescent glycolipids by lysosomal enzymes and their activators.
    Madar-Shapiro L; Pasmanik-Chor M; Dinur T; Dagan A; Gatt S; Horowitz M
    J Inherit Metab Dis; 1999 Jun; 22(5):623-37. PubMed ID: 10399095
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Saposins and their interaction with lipids.
    Vaccaro AM; Salvioli R; Tatti M; Ciaffoni F
    Neurochem Res; 1999 Feb; 24(2):307-14. PubMed ID: 9972880
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A kinetic study of the effects of galactocerebroside 3-sulphate on human spleen glucocerebrosidase. Evidence for two activator-binding sites.
    Prence EM; Garrett KO; Glew RH
    Biochem J; 1986 Aug; 237(3):655-62. PubMed ID: 3800908
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutation in saposin D domain of sphingolipid activator protein gene causes urinary system defects and cerebellar Purkinje cell degeneration with accumulation of hydroxy fatty acid-containing ceramide in mouse.
    Matsuda J; Kido M; Tadano-Aritomi K; Ishizuka I; Tominaga K; Toida K; Takeda E; Suzuki K; Kuroda Y
    Hum Mol Genet; 2004 Nov; 13(21):2709-23. PubMed ID: 15345707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.